| | IQWiG dossier assessment finds no added benefit of lixisenatide Fri, 02 Aug, 2013 11:49 PM PDT Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early be... Continue reading | | Nutrition tip of the week: The DASH Diet Fri, 02 Aug, 2013 10:14 PM PDT Have you heard of the DASH diet? Earlier this year, health professionals at U.S. News & World Report ranked 29 of the "Best Overall Diets," and the winner was the DASH diet. The diets were judged based on the following categories: short-term weight loss, long-term weight loss, easiness to follow, nutrition, s... Continue reading | |
No comments:
Post a Comment